Share This Article:
Human Longevity, a San Diego biotech company co-founded by the man who first sequenced DNA, has raised $220 million in a stock offering.
J. Craig Venter‘s company is creating the world’s largest database of whole genome, phenotype and clinical data and applying large scale computing techniques to make new medical discoveries.
The company said the financing was successful despite “challenging external financial markets.” Investors included Illumina, Celgene, GE Ventures.
“This is a tribute to the strength of our science, technology and team. We continue to build our business, develop life-changing products and hire world-class scientific, clinical and technical leaders to help us meet our goal of revolutionizing health care.,” said Venter, who serves as CEO.
Investment will go towards the company’s Health Nucleus, a genomic-enhanced, research-based health center, along with ongoing development of the database.
The company previously raised $80 million in its first stock offering, which closed in the summer of 2014.
>> Subscribe to Times of San Diego’s free daily email newsletter! Click here